Genome position and gene amplification

Genome Biology

Volumn 8, Issue 6, 2007, Pages

  Gajduskova, Pavla ^a,d   Snijders, Antoine M ^a   Kwek, Serena ^a   Roydasgupta, Ritu ^b   Fridlyand, Jane ^b,c   Tokuyasu, Taku ^b   Pinkel, Daniel ^b,c   Albertson, Donna G ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; METHOTREXATE; MUTANT PROTEIN; MYC PROTEIN;

AMPLICON; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG SENSITIVITY; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE INSERTION; GENE LOCATION; GENE TARGETING; GENETIC CODE; GENETIC ORGANIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METHOTREXATE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 36549034181     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2007-8-6-r120     Document Type: Article

References (77)

1. Miele M Bonatti S Menichini P Ottaggio L Abbondandolo A The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells. Mutat Res 1989 219 171-178 2567961
2. Murnane JP Sabatier L Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 2004 26 1164-1174 10.1002/bies.20125 15499579
3. Shimizu N Shingaki K Kaneko-Sasaguri Y Hashizume T Kanda T When, where and how the bridge breaks: Anaphase bridge breakage plays a crucial role in gene amplification and HSR generation. Exp Cell Res 2005 302 233-243 10.1016/j.yexcr.2004.09.001 15561104
4. Roth JR Andersson DI Amplification-mutagenesis - how growth under selection contributes to the origin of genetic diversity and explains the phenomenon of adaptive mutation. Res Microbiol 2004 155 342-351 10.1016/j.resmic.2004.01.016 15207866
5. Chernova OB Chernov MV Ishizaka Y Agarwal ML Stark GR MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol Cell Biol 1998 18 536-545 121521 9418900
6. Coquelle A Pipiras E Toledo F Buttin G Debatisse M Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 1997 89 215-225 10.1016/ S0092-8674(00)80201-9 9108477
7. Kuo MT Sen S Hittelman WN Hsu TC Chromosomal fragile sites and DNA amplification in drug-resistant cells. Biochem Pharmacol 1998 56 7-13 10.1016/S0006-2952(98)00040-9 9698083
8. Paulson TG Almasan A Brody LL Wahl GM Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol Cell Biol 1998 18 3089-3100 110691 9566927
9. Pipiras E Coquelle A Bieth A Debatisse M Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. Embo J 1998 17 325-333 1170383 9427766 10.1093/emboj/17.1.325
10. Barclay BJ Ondrusek NK Wildenhain YD Huang T Carlone RL Clement JM Wahl GM Effect of genomic position on amplification of the DFR1 gene in Saccharomyces cerevisiae. Adv Exp Med Biol 1993 338-545 550 8304177
11. Wahl GM Robert de Saint Vincent B DeRose ML Effect of chromosomal position on amplification of transfected genes in animal cells. Nature 1984 307 516-520 10.1038/307516a0 6694743
12. Kuo MT Vyas RC Jiang LX Hittelman WN Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol 1994 14 5202-5211 359039 7913517
13. Glover TW Common fragile sites. Cancer Lett 2006 232 4-12 10.1016/ j.canlet.2005.08.032 16229941
14. Miller CT Lin L Casper AM Lim J Thomas DG Orringer MB Chang AC Chambers AF Giordano TJ Glover TW Beer DG Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 2006 25 409-418 16186806
15. Banerjee D Mayer-Kuckuk P Capiaux G Budak-Alpdogan T Gorlick R Bertino JR Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 2002 1587 164-173 12084458
16. Matherly LH Molecular and cellular biology of the human reduced folate carrier. Prog Nucleic Acid Res Mol Biol 2001 67 131-162 11525381
17. Snijders AN Fridlyand J Mans D Segraves R Jain AN Pinkel D Albertson DG Shaping tumor and drug resistant genomes by instability and selection. Oncogene 2003 22 4370-4379 10.1038/sj.onc.1206482 12853973
18. Koi M Umar A Chauhan DP Cherian SP Carethers JM Kunkel TA Boland CR Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 1994 54 4308-4312 8044777
19. Albertson DG Gene amplification in cancer. Trends Genet 2006 22 447-455 10.1016/j.tig.2006.06.007 16787682
20. Krzywinski M Bosdet I Smailus D Chiu R Mathewson C Wye N Barber S Brown-John M Chan S Chand S A et al. set of BAC clones spanning the human genome. Nucleic Acids Res 2004 32 3651-3660 484185 15247347 10.1093/nar/gkh700
21. Zeller KI Jegga AG Aronow BJ O'Donnell KA Dang CV An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 2003 4 R69 328458 14519204 10.1186/gb-2003-4-10-r69
22. Garcia MJ Pole JC Chin SF Teschendorff A Naderi A Ozdag H Vias M Kranjac T Subkhankulova T Paish C A et al. 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 2005 24 5235-5245 10.1038/sj.onc.1208741 15897872
23. Ray ME Yang ZQ Albertson D Kleer CG Washburn JG Macoska JA Ethier SP Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 2004 64 40-47 10.1158/ 0008-5472.CAN-03-1022 14729606
24. Kauraniemi P Barlund M Monni O Kallioniemi A New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 2001 61 8235-8240 11719455
25. Rossi MR La Duca J Matsui S Nowak NJ Hawthorn L Cowell JK Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme. Genes Chromosomes Cancer 2005 44 392-404 10.1002/gcc.20256 16110500
26. Evans AJ Gallie BL Jewett MA Pond GR Vandezande K Underwood J Fradet Y Lim G Marrano P Zielenska M Squire JA Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. Am J Pathol 2004 164 285-293 1602217 14695341
27. Snijders AM Schmidt BL Fridlyand J Dekker N Pinkel D Jordan RC Albertson DG Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 2005 24 4232-4242 10.1038/sj.onc.1208601 15824737
28. Imoto I Yang ZQ Pimkhaokham A Tsuda H Shimada Y Imamura M Ohki M Inazawa J Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 2001 61 6629-6634 11559525
29. Dai Z Zhu WG Morrison CD Brena RM Smiraglia DJ Raval A Wu YZ Rush LJ Ross P Molina JR et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum Mol Genet 2003 12 791-801 10.1093/hmg/ddg083 12651874
30. Bashyam MD Bair R Kim YH Wang P Hernandez-Boussard T Karikari CA Tibshirani R Maitra A Pollack JR Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 2005 7 556-562 1501288 16036106 10.1593/neo.04586
31. Zender L Spector MS Xue W Flemming P Cordon-Cardo C Silke J Fan ST Luk JM Wigler M Hannon GJ et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006 125 1253-1267 10.1016/j.cell.2006.05.030 16814713
32. Grondin K Roy G Ouellette M Formation of extrachromosomal circular amplicons with direct or inverted duplications in drug-resistant Leishmania tarentolae. Mol Cell Biol 1996 16 3587-3595 231354 8668175
33. Grondin K Papadopoulou B Ouellette M Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania. Nucleic Acids Res 1993 21 1895-1901 309430 8098523 10.1093/nar/21.8.1895
34. Kundig C Leblanc E Papadopoulou B Ouellette M Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae. Nucleic Acids Res 1999 27 3653-3659 148619 10471733 10.1093/nar/27.18.3653
35. Sheaff RJ Groudine M Gordon M Roberts JM Clurman BE Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997 11 1464-1478 10.1101/gad.11.11.1464 9192873
36. Kauraniemi P Kallioniemi A Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer. Endocr Relat Cancer 2006 13 39-49 10.1677/erc.1.01147 16601278
37. Kanno M Hasegawa M Ishida A Isono K Taniguchi M mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. Embo J 1995 14 5672-5678 394682 8521824
38. Tetsu O Ishihara H Kanno R Kamiyasu M Inoue H Tokuhisa T Taniguchi M Kanno M mel-18 negatively regulates cell cycle progression upon B cell antigen receptor stimulation through a cascade leading to c-myc/cdc25. Immunity 1998 9 439-448 10.1016/S1074-7613(00)80627-5 9806630
39. Guo WJ Datta S Band V Dimri GP Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 2007 18 536-546 1783768 17151361 10.1091/mbc.E06-05-0447
40. LeBeau MM Rowley JD Heritable fragile sites in cancer. Nature 1984 308 607-608 10.1038/308607a0 6709072
41. Yunis JJ Soreng AL Constitutive fragile sites and cancer. Science 1984 226 1199-1204 10.1126/science.6239375 6239375
42. Mitchell PJ Urlaub G Chasin L Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol Cell Biol 1986 6 1926-1935 367730 3023911
43. Kim R Trubetskoy A Suzuki T Jenkins NA Copeland NG Lenz J Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J Virol 2003 77 2056-2062 140962 12525640 10.1128/JVI.77.3.2056-2062.2003
44. Li J Shen H Himmel KL Dupuy AJ Largaespada DA Nakamura T Shaughnessy JD Jr Jenkins NA Copeland NG Leukaemia disease genes: Large-scale cloning and pathway predictions. Nat Genet 1999 23 348-353 10.1038/15531 10610183
45. Kent WJ Sugnet CW Furey TS Roskin KM Pringle TH Zahler AM Haussler D The human genome browser at UCSC. Genome Res 2002 12 996-1006 186604 12045153 10.1101/gr.229102. Article published online before print in May 2002
46. Kent WJ BLAT - the BLAST-like alignment tool. Genome Res 2002 12 656-664 187518 11932250 10.1101/gr.229202. Article published online before March 2002
47. Hamilton G Brown N Oseroff V Huey B Segraves R Sudar D Kumler J Albertson D Pinkel D A large field CCD system for quantitative imaging of microarrays. Nucleic Acids Res 2006 34 e58 1456328 16670425 10.1093/ nar/gkl160
48. Pinkel D Segraves R Sudar D Clark S Poole I Kowbel D Collins C Kuo WL Chen C Zhai Y et al High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998 20 207-211 10.1038/2524 9771718
49. NCBI GEO http://www.ncbi.nlm.nih.gov/geo/
50. Operon V2.0 http://www.gladstone.ucsf.edu/gladstone/site/genomicscore/ section.php?id=1477
51. Jain AN Tokuyasu TA Snijders AM Segraves R Albertson DG Pinkel D Fully automatic quantification of microarray image data. Genome Res 2002 12 325-332 155276 11827952 10.1101/gr.210902
52. Royce TE Rozowsky JS Luscombe NM Emanuelsson O Yu H Zhu X Snyder M Gerstein MB Extrapolating traditional DNA microarray statistics to tiling and protein microarray technologies. Methods Enzymol 2006 411 282-311 16939796
53. Royce TE Rozowsky JS Gerstein MB Assessing the need for sequence-based normalization in tiling microarray experiments. Bioinformatics 2007 23 988-997 10.1093/bioinformatics/btm052 17387113
54. Neuvial P Hupe P Brito I Liva S Manie E Brennetot C Radvanyi F Aurias A Barillot E Spatial normalization of array-CGH data. BMC Bioinformatics 2006 7 264 1523216 16716215 10.1186/1471-2105-7-264
55. Hastie TJ Tibshirani RJ Generalized additive models, volume 43 of Monographs on Statistics and Applied Probability New York Chapman and Hall 1 1990
56. Tonon G Wong KK Maulik G Brennan C Feng B Zhang Y Khatry DB Protopopov A You MJ Aguirre AJ et al. High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 2005 102 9625-9630 1160520 15983384 10.1073/pnas.0504126102
57. Pinkel D Albertson DG Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005 37 Suppl S11-17 10.1038/ng1569 15920524
58. Fridlyand J Snijders AM Ylstra B Li H Olshen A Segraves R Dairkee S Tokuyasu T Ljung BM Jain AN et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 2006 6 96 1459181 16620391 10.1186/1471-2407-6-96
59. Olshen AB Venkatraman ES Lucito R Wigler M Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004 5 557-572 10.1093/biostatistics/kxh008 15475419
60. http://bioconductor.org/packages/1.8/bioc/html/DNAcopy.html
61. Willenbrock H Fridlyand J A comparison study: Applying segmentation to array CGH data for downstream analyses. Bioinformatics 2005 21 4084-4091 10.1093/bioinformatics/bti677 16159913
62. Neve RM Ylstra B Chang CH Albertson DG Benz CC ErbB2 activation of ESX gene expression. Oncogene 2002 21 3934-3938 10.1038/sj.onc.1205503 12032832
63. Vogt N Lefevre SH Apiou F Dutrillaux AM Cor A Leuraud P Poupon MF Dutrillaux B Debatisse M Malfoy B Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc Natl Acad Sci U S A 2004 101 11368-11373 509208 15269346 10.1073/pnas.0402979101
64. NCBI Reference Sequences (RefSeq) http://www.ncbi.nlm.nih.gov/RefSeq/
65. Limongi MZ Pelliccia F Rocchi A Characterization of the human common fragile site FRA2G. Genomics 2003 81 93-97 10.1016/S0888-7543(03)00007-7 12620385
66. Rozier L El-Achkar E Apiou F Debatisse M Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer. Oncogene 2004 23 6872-6880 10.1038/sj.onc.1207809 15286716
67. Zlotorynski E Rahat A Skaug J Ben-Porat N Ozeri E Hershberg R Levi A Scherer SW Margalit H Kerem B Molecular basis for expression of common and rare fragile sites. Mol Cell Biol 2003 23 7143-7151 230307 14517285 10.1128/MCB.23.20.7143-7151.2003
68. Morelli C Karayianni E Magnanini C Mungall AJ Thorland E Negrini M Smith DI Barbanti-Brodano G Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene 2002 21 7266-7276 10.1038/ sj.onc.1205573 12370818
69. Mishmar D Rahat A Scherer SW Nyakatura G Hinzmann B Kohwi Y Mandel-Gutfroind Y Lee JR Drescher B Sas DE et al. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A 1998 95 8141-8146 20943 9653154 10.1073/pnas.95.14.8141
70. Ciullo M Debily MA Rozier L Autiero M Billault A Mayau V El Marhomy S Guardiola J Bernheim A Coullin P et al. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: The model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 2002 11 2887-2894 10.1093/hmg/11.23.2887 12393800
71. Ferber MJ Thorland EC Brink AA Rapp AK Phillips LA McGovern R Gostout BS Cheung TH Chung TK Fu WY Smith DI Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003 22 7233-7242 10.1038/sj.onc.1207006 14562053
72. Ferber MJ Montoya DP Yu C Aderca I McGee A Thorland EC Nagorney DM Gostout BS Burgart LJ Boix L et al. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 2003 22 3813-3820 10.1038/sj.onc.1206528 12802289
73. Callahan G Denison SR Phillips LA Shridhar V Smith DI Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 2003 22 590-601 10.1038/sj.onc.1206171 12555072
74. Sarafidou T Kahl C Martinez-Garay I Mangelsdorf M Gesk S Baker E Kokkinaki M Talley P Maltby EL French L et al. Folate-sensitive fragile site FRA10A is due to an expansion of a CGG repeat in a novel gene, FRA10AC1, encoding a nuclear protein. Genomics 2004 84 69-81 10.1016/ j.ygeno.2003.12.017 15203205
75. Jones C Penny L Mattina T Yu S Baker E Voullaire L Langdon WY Sutherland GR Richards RI Tunnacliffe A Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 1995 376 145-149 10.1038/376145a0 7603564
76. Savelyeva L Sagulenko E Schmitt JG Schwab M The neurobeachin gene spans the common fragile site FRA13A. Hum Genet 2006 118 551-558 10.1007/ s00439-005-0083-z 16244873
77. Yu S Mangelsdorf M Hewett D Hobson L Baker E Eyre HJ Lapsys N Le Paslier D Doggett NA Sutherland GR Richards RI Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 1997 88 367-374 10.1016/S0092-8674(00)81875-9 9039263